Provided are an amine compound represented by Formula 1, a resist composition including the same, and a method of forming a pattern by using the same:

##STR00001## wherein detailed descriptions of A.sub.11, A.sub.12, k.sub.11, n.sub.11, R.sub.11 to R.sub.14, b11 and b12 in Formula 1 are provided in the present specification.

Provided are an amine compound represented by Formula 1, a resist composition including the same, and a method of forming a pattern by using the same:

##STR00001## wherein detailed descriptions of A.sub.11, A.sub.12, k.sub.11, n.sub.11, R.sub.11 to R.sub.14, b11 and b12 in Formula 1 are provided in the present specification.

Provided is a stacked organic electroluminescence device. At least one light-emitting unit of the stacked organic electroluminescent device includes an organic layer including a specific combination of a P-type material with a deep LUMO energy level and a hole transporting material with a deep HOMO energy level. Meanwhile, a P-type material is used as the buffer layer of the charge generation layer between the light-emitting units. The device can offer better device performance and more simplified fabrication process. Further provided is a display assembly including the device.

An organic compound is represented by Chemical Formula 1. ##STR00001##
In Chemical Formula 1, X.sup.1, X.sup.2, Ar.sup.1, n, R.sup.1, R.sup.2, A.sup.1, and A.sup.2 are each the same as in the specification.

An organic compound is represented by Chemical Formula 1. ##STR00001##
In Chemical Formula 1, X.sup.1, X.sup.2, Ar.sup.1, n, R.sup.1, R.sup.2, A.sup.1, and A.sup.2 are each the same as in the specification.

The present invention relates to a novel cancer curing deuterated selenopheno [h] chromene derivatives, as well as methods of their manufacturing and use in different pharmaceutical compositions for the treatment of cancer by administration of such substances.

The present invention relates to a novel cancer curing deuterated selenopheno [h] chromene derivatives, as well as methods of their manufacturing and use in different pharmaceutical compositions for the treatment of cancer by administration of such substances.

A compound is represented by Chemical Formula 1. ##STR00001## In Chemical Formula 1, G, R.sup.1, R.sup.2, R.sup.3, X.sup.1, Ar.sup.1 and Ar.sup.2 are each the same as in the specification.

A compound is represented by Chemical Formula 1. ##STR00001## In Chemical Formula 1, G, R.sup.1, R.sup.2, R.sup.3, X.sup.1, Ar.sup.1 and Ar.sup.2 are each the same as in the specification.